Heliyon · 2020 · 40 citations · 25 references
PharmacyMedicinal ChemistryPharmacologyComputational ChemistryComputational Medicinal ChemistryDrug DiscoveryLigand BindingMolecular DockingMolecular ModelingProtein-ligand DockingQuantitative Structure-activity RelationshipsVirtual ScreeningDocking StudiesDocking ValidationDocking-based Drug DesignDocking-based Pharmacophore DesignLinear RegressionMolecular Docking AnalysisMultiple Regression
) the known inhibitor of the target (V600E-BRAF). These findings may be very helpful in early anti-cancer drug development.
25
Computer Aided Design of Experiments
R. W. Kennard, L. A. Stone · Technometrics · 1969 · 3.4K citations
Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma
Gideon Bollag, Peter Hirth, James Tsai et al. · Nature · 2010 · 1.8K citations
Medicine, Oncology, Pharmacology +14
BRAF and RAS mutations in human lung cancer and melanoma.
Marcia S. Brose, Patrícia Volpe, Michael D. Feldman et al. · PubMed · 2002 · 1K citations